170 related articles for article (PubMed ID: 3022897)
1. [Viruses and human cancers: fundamental aspects and hopes of prevention].
de Thé G
C R Seances Soc Biol Fil; 1986; 180(3):249-61. PubMed ID: 3022897
[No Abstract] [Full Text] [Related]
2. Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.
Epstein MA; Morgan AJ
Clin Exp Immunol; 1983 Aug; 53(2):257-71. PubMed ID: 6309441
[No Abstract] [Full Text] [Related]
3. Epstein-Barr virus. Is it timely to discuss a vaccine?
Biomedicine; 1978; 28(1):15-7. PubMed ID: 208671
[No Abstract] [Full Text] [Related]
4. [Role of the Epstein-Barr virus in human pathology].
Rupniewska ZM
Acta Haematol Pol; 1979; 10(3):183-91. PubMed ID: 228518
[No Abstract] [Full Text] [Related]
5. IgA and nasopharyngeal carcinoma.
Desgranges C; De-The G
IARC Sci Publ (1971); 1978; (24 Pt 2):883-91. PubMed ID: 221410
[No Abstract] [Full Text] [Related]
6. Evidence for an oncogenic potential of the Epstein-Barr virus.
Henle W; Henle G
Cancer Res; 1973 Jun; 33(6):1419-23. PubMed ID: 4352376
[No Abstract] [Full Text] [Related]
7. Herpes viruses and oncogenesis.
Klein G
Johns Hopkins Med J Suppl; 1974; 3():15-25. PubMed ID: 4370988
[No Abstract] [Full Text] [Related]
8. The EB virus.
Epstein MA; Achong BG
Annu Rev Microbiol; 1973; 27():413-36. PubMed ID: 4356531
[No Abstract] [Full Text] [Related]
9. [Present status of infectious mononucleosis and Epstein Barr virus].
Ducroix JP; Smail A; Vovan AT; Devauchelle B; Baillet J
LARC Med; 1984 Mar; 4(3):161-3. PubMed ID: 6325836
[No Abstract] [Full Text] [Related]
10. [Epstein-Barr virus infection: immunology and immunopathology].
Geelen SP; Kuis W; Roord JJ; Stoop JW; Kapsenberg JG
Ned Tijdschr Geneeskd; 1986 Jan; 130(2):63-7. PubMed ID: 3005887
[No Abstract] [Full Text] [Related]
11. A prototype vaccine to prevent Epstein-Barr virus-associated cancers.
Epstein M
Chemioterapia; 1987 Jun; 6(2 Suppl):655-8. PubMed ID: 2855615
[No Abstract] [Full Text] [Related]
12. Epstein-Barr virus, infectious mononucleosis, Burkitt's lymphoma and nasopharyngeal carcinoma.
Klein G
Isr J Med Sci; 1977 Jul; 13(7):716-24. PubMed ID: 200586
[No Abstract] [Full Text] [Related]
13. Clinical implications of immunity to oncogenic viruses.
Levine PH
Contemp Top Immunobiol; 1977; 6():263-86. PubMed ID: 194750
[No Abstract] [Full Text] [Related]
14. [Cell membrane receptor of cultured cells derived from nasopharyngeal carcinoma, Burkitt's lymphoma and infectious mononucleosis].
Nishioka K; Tachibana T; Hirayama T; De Thé G; Klein G
Nihon Ishikai Zasshi; 1971 Jun; 65(11):1398-406. PubMed ID: 4326465
[No Abstract] [Full Text] [Related]
15. Epstein-Barr virus infections.
Middleton PJ
Can Med Assoc J; 1974 Jan; 110(1):9-10. PubMed ID: 4358535
[No Abstract] [Full Text] [Related]
16. [Burkitt's lymphoma].
Gombos F; Serpico R; Femiano F
Arch Stomatol (Napoli); 1984; 25(4):329-38. PubMed ID: 6100729
[No Abstract] [Full Text] [Related]
17. Epstein-barr-virus nuclear antigen.
Vonka V; Hirsch I
Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
[No Abstract] [Full Text] [Related]
18. The EB virus in relation to infectious mononucleosis.
Sutton RN
J Clin Pathol Suppl (R Coll Pathol); 1972; 6():58-64. PubMed ID: 4376156
[No Abstract] [Full Text] [Related]
19. Epstein-Barr virus-related serology in Hodgkin's disease.
Henle W; Henle G
Natl Cancer Inst Monogr; 1973 May; 36():79-84. PubMed ID: 4355353
[No Abstract] [Full Text] [Related]
20. Issues related to development of Epstein-Barr virus vaccines.
Spring SB; Hascall G; Gruber J
J Natl Cancer Inst; 1996 Oct; 88(20):1436-41. PubMed ID: 8841018
[No Abstract] [Full Text] [Related]
[Next] [New Search]
